Summary
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
Register to download
Persistence Leads To High Enrollment
You may also be interested in:
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 1
As the oncology environment continues to grow towards more targeted therapies, it is imperative that patient recruitment strategies focus on how to…
View Resource
Blog
International Master’s Program Prepares Doctors, Scientists, Researchers for Careers in Vaccines, Drug Development
Siena, a city in Tuscany, Italy and capital of the province of Siena, is one of the nation's most visited tourist destinations, known for its…
Read Story
page
Company History
Read More
View all related content and resources for Clinical Development
Explore Insights